generic drugs
See the following -
Brand-Name Drugs Pushing Up US Medicare Costs: Survey
People with diabetes who are enrolled in the US federal Medicare health programme are two to three times more likely to use "expensive" brand-name drugs than diabetes patients who are treated within the Veterans Administration (VA) Healthcare System, new research shows. Read More »
- Login to post comments
Don't Trade Away Our Health
A secretive group met behind closed doors in New York this week. What they decided may lead to higher drug prices for you and hundreds of millions around the world...
- Login to post comments
Free Drug Samples Prompt Skin Doctors To Prescribe Costlier Meds
Dermatologists who accept free tubes and bottles of brand-name drugs are likelier to prescribe expensive medications for acne than doctors who are prohibited from taking samples, a study reports Wednesday. The difference isn't chump change.
- Login to post comments
Free Drugs? India Mulls a New Assault on Big Pharma
...now it seems India is considering offering generic drugs for free to patients at government-run clinics. After Prime Minister Manmohan Singh backed the scheme, the Planning Commission has reportedly allocated $18 million to start the ball rolling.
- Login to post comments
Generic Drugs Don't Necessarily Mean Low Prices
NewsHour Weekend's Megan Thompson reports on the surprising disparity in pricing for generic drugs. Generics, generally thought to be cheap, can actually vary widely in price from pharmacy to pharmacy, causing some to skip medications altogether. Read More »
- Login to post comments
Medicare Prescribes More Brand Name Drugs Than VA
Medicare Part D beneficiaries are two to three times more likely than those covered by the U.S. Department of Veterans Affairs to be prescribed brand name diabetes drugs rather than generics, a new study suggests. Read More »
- Login to post comments
Merck 'Evergreens' Off-Patent Lipitor By Creating Combination Drug With No Additional Benefit
Big pharma often gets a rather rough ride here on Techdirt, what with its attempts to stop governments granting licenses for life-saving and low-cost generics in emerging countries, engaging in legal action to prevent drug safety information being released, and paying kickbacks to doctors. Read More »
- Login to post comments
New Drugs Trail Many Old Ones In Effectiveness Against Disease
Despite the more than $50 billion that U.S. pharmaceutical companies have spent every year since the mid-2000s to discover new medications, drugmakers have barely improved on old standbys developed decades ago. Read More »
- Login to post comments
NY Attorney General Confirms Real-Life Conspiracy Among Drug Companies
The office of the New York Attorney General and the American units of Ranbaxy Laboratories Ltd. and Teva Pharmaceutical Industries Ltd. have come to terms on a settlement involving claims that an agreement between the two Big Pharma companies restricted competition unlawfully. Read More »
- Login to post comments
Pharmaceutical CEO Says His Cancer-Fighting Drugs Aren't For Poor People
Big pharmaceutical companies constantly compete with one another to come up with the next "superstar" life-saving drug. But when the cure becomes a means of making money rather than a way to save lives, maybe they should refocus their mission statements.
- Login to post comments
Soaring Generic Drug Prices Draw Senate Scrutiny
Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington lawmakers...
- Login to post comments
Study: Brand Name Drugs Drive Up Medicare Spending
A new study suggests that cash-strapped Medicare missed an opportunity to save more than $1 billion by not addressing the varying costs and use of prescription drugs. Read More »
- Login to post comments
Top Medicare Prescribers Rake In Speaking Fees From Drugmakers
When the blood pressure drug Bystolic hit the market in 2008, it faced a crowded field of cheap generics. So its maker, Forest Laboratories, launched a promotional assault [...]. It flooded the offices of health professionals with drug reps, and it hired doctors to persuade their peers to choose Bystolic — even though the drug hadn't proved more effective than competitors. Read More »
- Login to post comments
TPP Treaty Could be a Serious Threat to US Public Health System
While trade agreements may seem to be another, albeit international species of wonkery, these agreements could have major effects on patients' and the public's health. Since these concerns have been essentially ignored by the US medical and health care literature, (although they have appeared in UK journals, Australian, and New Zealand journals in English), they I will discuss them below. Worthy of further discussion is the possibility that these potential threats to health care and public health may arise not just from ideological disagreements, but also from health care corporations' increasing capture of government, facilitated by the conflicts of interest generated by the revolving door. Read More »
- Login to post comments